price controls
In today s you could have predicted this department, we are
The recent approval and marketing of Gilead s hepatitis-C drug, Sovaldi, has spurred a revolt against expensive
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
